Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morrison

Showing results (521-530 of 621) with videos related to

Pageof 63
Sort By:
The Lancet. Psychiatry|July 14, 2018
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trialAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
BMC Psychiatry|August 7, 2016
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trialMelissa Pyle, John Norrie, Matthias Schwannauer, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
Journal of Mental Health (Abingdon, England)|December 23, 2017
Delivery of cognitive-behaviour therapy for psychosis: a service user preference trialGillian Haddock, Katherine Berry, Gabriel Davies, et al.
The Lancet. Psychiatry|April 2, 2018
Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility studyAnthony P Morrison, Heather Law, Lucy Carter, et al.
Health Technology Assessment (Winchester, England)|January 26, 2021
Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCTAnthony P Morrison, Melissa Pyle, Rory Byrne, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trialAnthony P Morrison, Paul French, Suzanne L K Stewart, et al.
Health Technology Assessment (Winchester, England)|February 27, 2019
Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCTAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
Eclinicalmedicine|August 12, 2025
Examining the feasibility of a crisis-focused Cognitive Behaviour Therapy (CBT)-informed psychological intervention for inpatients experiencing psychosis (the CRISIS study): results from a pilot randomised controlled trialLisa Wood, Anthony P Morrison, Mary Birken, et al.
Trials|July 6, 2019
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)Melissa Pyle, Matthew R Broome, Emmeline Joyce, et al.
Pageof 63

Showing results (521-530 of 621) with videos related to

Sort By:
Pageof 63
The Lancet. Psychiatry|July 14, 2018
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trialAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
BMC Psychiatry|August 7, 2016
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trialMelissa Pyle, John Norrie, Matthias Schwannauer, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
Journal of Mental Health (Abingdon, England)|December 23, 2017
Delivery of cognitive-behaviour therapy for psychosis: a service user preference trialGillian Haddock, Katherine Berry, Gabriel Davies, et al.
The Lancet. Psychiatry|April 2, 2018
Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility studyAnthony P Morrison, Heather Law, Lucy Carter, et al.
Health Technology Assessment (Winchester, England)|January 26, 2021
Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCTAnthony P Morrison, Melissa Pyle, Rory Byrne, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trialAnthony P Morrison, Paul French, Suzanne L K Stewart, et al.
Health Technology Assessment (Winchester, England)|February 27, 2019
Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCTAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
Eclinicalmedicine|August 12, 2025
Examining the feasibility of a crisis-focused Cognitive Behaviour Therapy (CBT)-informed psychological intervention for inpatients experiencing psychosis (the CRISIS study): results from a pilot randomised controlled trialLisa Wood, Anthony P Morrison, Mary Birken, et al.
Trials|July 6, 2019
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)Melissa Pyle, Matthew R Broome, Emmeline Joyce, et al.
Pageof 63